TP53 and cancer: Previous studies have found that co-expression of p53 and pRb in cancer cells with compromised p53 and pRb activity inhibited p53 mediated apoptosis and promoted cell cycle arrest suggesting p53 and pRb crosstalk to regulate cellular fate [35, 36].